Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — Net Asset Quality Index

Latest as of March 2026: 96.4%

Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Net Asset Quality Index of 96.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.02 Billion minus total liabilities of CN¥36.47 Million yields net assets of CN¥983.66 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 600381 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Quality Index

96.4%
Equity / Total Assets

Net Assets

CN¥983.66 Million
CNY

Total Assets

CN¥1.02 Billion
CNY

Total Liabilities

CN¥36.47 Million
CNY

Qinghai Spring Medicinal Resources Technology Co Ltd Net Asset Quality Index Over Time (1998–2025)

This chart shows how Qinghai Spring Medicinal Resources Technology Co Ltd's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of March 2026, the index stands at 96.4%, representing net assets of CN¥983.66 Million against total assets of CN¥1.02 Billion CNY. Explore 600381 operating cash flow to assess how effectively this company generates cash.

Annual Net Asset Quality Index for Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)

The table below presents the year-by-year Net Asset Quality Index for Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Qinghai Spring Medicinal Resources Techn stock valuation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 95.7% CN¥999.61 Million CN¥1.04 Billion CN¥44.87 Million ▲ +6.7 pp
2024 89.0% CN¥1.04 Billion CN¥1.16 Billion CN¥128.02 Million ▼ -4.2 pp
2023 93.2% CN¥1.27 Billion CN¥1.36 Billion CN¥91.99 Million ▼ -5.1 pp
2022 98.3% CN¥1.53 Billion CN¥1.56 Billion CN¥26.30 Million ▼ -0.2 pp
2021 98.5% CN¥1.82 Billion CN¥1.85 Billion CN¥27.64 Million ▲ +4.7 pp
2020 93.8% CN¥2.07 Billion CN¥2.21 Billion CN¥137.08 Million ▼ -5.4 pp
2019 99.2% CN¥2.39 Billion CN¥2.41 Billion CN¥20.14 Million ▲ +1.3 pp
2018 97.8% CN¥2.38 Billion CN¥2.44 Billion CN¥52.68 Million ▲ +2.5 pp
2017 95.3% CN¥2.32 Billion CN¥2.43 Billion CN¥113.56 Million ▲ +4.7 pp
2016 90.6% CN¥2.00 Billion CN¥2.21 Billion CN¥206.95 Million ▲ +7.4 pp
2015 83.2% CN¥1.76 Billion CN¥2.11 Billion CN¥354.60 Million ▲ +61.7 pp
2014 21.5% CN¥308.44 Million CN¥1.44 Billion CN¥1.13 Billion ▲ +18.1 pp
2013 3.4% CN¥50.03 Million CN¥1.49 Billion CN¥1.44 Billion ▼ -49.8 pp
2012 53.1% CN¥2.15 Billion CN¥4.05 Billion CN¥1.90 Billion ▼ -5.8 pp
2011 58.9% CN¥2.32 Billion CN¥3.94 Billion CN¥1.62 Billion ▲ +73.0 pp
2010 -14.1% CN¥-116.10 Million CN¥822.48 Million CN¥938.58 Million ▲ +37.1 pp
2009 -51.3% CN¥-178.12 Million CN¥347.49 Million CN¥525.60 Million ▲ +13.2 pp
2008 -64.4% CN¥-230.81 Million CN¥358.21 Million CN¥589.02 Million ▲ +40.5 pp
2007 -105.0% CN¥-362.40 Million CN¥345.21 Million CN¥707.61 Million ▼ -5.9 pp
2006 -99.0% CN¥-429.60 Million CN¥433.78 Million CN¥863.38 Million ▼ -122.9 pp
2005 23.9% CN¥327.77 Million CN¥1.37 Billion CN¥1.05 Billion ▼ -4.7 pp
2004 28.6% CN¥489.71 Million CN¥1.71 Billion CN¥1.22 Billion ▼ -4.6 pp
2003 33.1% CN¥391.64 Million CN¥1.18 Billion CN¥789.85 Million ▼ -12.7 pp
2002 45.8% CN¥351.79 Million CN¥767.69 Million CN¥415.90 Million ▼ -9.9 pp
2001 55.8% CN¥333.98 Million CN¥598.92 Million CN¥264.94 Million ▲ +17.2 pp
2000 38.5% CN¥117.80 Million CN¥305.71 Million CN¥187.91 Million ▼ -8.4 pp
1999 47.0% CN¥113.38 Million CN¥241.42 Million CN¥128.04 Million ▲ +3.0 pp
1998 44.0% CN¥93.87 Million CN¥213.35 Million CN¥119.48 Million
pp = percentage points